Carcinoma: all 6,718 studies
Page 41 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.TerminatedNCT03628079Phase 1/2
- Endoscopic Robot-Assisted Simple Enucleation Versus Standard Robot-Assisted Partial Nephrectomy in the Treatment of T1 Renal Cell CarcinomaActive, not recruitingNCT03624673Not applicable
- Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCCStatus unknownNCT03623737Phase 2/3
- Elucid Labs AIDA™ - Labelled Image Acquisition ProtocolStatus unknownNCT03621462Not applicable
- A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and NeckCompletedNCT03620123Phase 2
- Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell LineStatus unknownNCT03619304Not applicable
- Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6CompletedNCT03618758Phase 1/2
- Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell CarcinomaCompletedNCT03618654Early Phase 1
- EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT03618381Phase 1
- Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell CanerTerminatedNCT03618134Phase 1/2
- Clinical Trial of Radiotherapy in Treating Primary Hepatocellular CarcinomaStatus unknownNCT03614546Not applicable
- Combination of Nanoxel and Herzuma in Salivary Duct CarcinomaStatus unknownNCT03614364Phase 2
- ANG1005 in Leptomeningeal Disease From Breast CancerStatus unknownNCT03613181Phase 3
- Cabozantinib in Advanced Adrenocortical CarcinomaActive, not recruitingNCT03612232Phase 2
- Adjuvant Treatment of Apatinib in Nasopharyngeal CarcinomaStatus unknownNCT03612219Phase 2
- Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation TherapyWithdrawnNCT03611205Not applicable
- Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs SurgeryCompletedNCT03610620Not applicable
- Acelarin First Line Randomised Pancreatic StudySuspendedNCT03610100Phase 2/3
- A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary CarcinomaStatus unknownNCT03609489Phase 2
- Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular CarcinomaStatus unknownNCT03609268Not applicable
- Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular CarcinomaStatus unknownNCT03609151Not applicable
- Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in HCC Patients With GALNT14-rs9679162-non-TT GenotypeTerminatedNCT03608878Phase 2
- Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)CompletedNCT03606590Phase 2
- A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.Status unknownNCT03605706Phase 3
- GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPCStatus unknownNCT03604965Phase 3
- Analysis of the Curative Effect of Salvage Surgery on Recurrent Laryngeal CarcinomaCompletedNCT03604601
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/2
- Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal CarcinomaStatus unknownNCT03601975Phase 3
- Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPCCompletedNCT03601390
- Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT03600831Phase 2/3
- PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell CarcinomaWithdrawnNCT03598816Phase 2
- Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal CarcinomaCompletedNCT03598218Not applicable
- Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand TherapyWithdrawnNCT03596710Not applicable
- Effects of Anesthetic Methods on Hepatic Cancer Cell MalignancyCompletedNCT03594188Not applicable
- Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line AxitinibStatus unknownNCT03592199Phase 2
- Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) SubjectsTerminatedNCT03591965Phase 2
- Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesCompletedNCT03590054Phase 1
- TOMO Versus IMRT in Nasopharyngeal Carcinoma PatientsStatus unknownNCT03588403
- Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal CarcinomaStatus unknownNCT03585673Phase 2
- Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of EsophagusStatus unknownNCT03585530Phase 2
- CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular CarcinomaTerminatedNCT03582618Phase 2
- A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma PatientsStatus unknownNCT03581435
- SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCCCompletedNCT03578874Phase 2
- To Investigate the Molecular Mechanism of Traditional Chinese Medicine Constitution Using Next-generation Sequencing in Nasopharyngeal CarcinomaStatus unknownNCT03578575Phase 2
- Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal CancerWithdrawnNCT03576963Phase 1/2
- Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity StudyCompletedNCT03575598Early Phase 1
- Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal CancerWithdrawnNCT03575234Phase 1
- TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPCStatus unknownNCT03574324Phase 3
- Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular CarcinomaCompletedNCT03572582Phase 2
- Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol MebutateCompletedNCT03569345Phase 1/2
- Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal CarcinomaStatus unknownNCT03568032
- Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular CarcinomaCompletedNCT03564405Not applicable
- Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerWithdrawnNCT03563352
- QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) VaccineWithdrawnNCT03563170Phase 1/2
- New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal CarcinomaStatus unknownNCT03558035Phase 2
- Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the CervixCompletedNCT03556839Phase 3
- 89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSECompletedNCT03556046Phase 1
- Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell CarcinomaCompletedNCT03554967
- An Expanded Access Program for AM0010 (Pegilodecakin)No longer availableNCT03554434
- T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast CancerCompletedNCT03554044Phase 1
- sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder CancerWithdrawnNCT03552796Phase 1
- Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants with Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT03552471Phase 1
- Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 TrialStatus unknownNCT03551444Phase 3
- NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial CarcinomaActive, not recruitingNCT03549715Phase 1/2
- Dietary Factors and Risk of Gallbladder Carcinoma in ChinaStatus unknownNCT03546296
- Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell CarcinomaCompletedNCT03546166Phase 2
- Feasibility and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial CarcinomaStatus unknownNCT03544437
- Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNATerminatedNCT03544099Phase 2
- MRI in Ductal Carcinoma in Situ (DCIS)Status unknownNCT03543397
- ctDNA as a Biomarker for Treatment Response in HNSCCCompletedNCT03540563Not applicable
- Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.CompletedNCT03540407Phase 2
- Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma PatientsCompletedNCT03539406Phase 1
- A Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesCompletedNCT03538028Phase 1
- Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular CarcinomaCompletedNCT03535259Phase 2
- A Comparison Between Child-Pugh and Albumin-Bilirubin ScoresCompletedNCT03534843
- Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular CarcinomaCompletedNCT03533920Not applicable
- Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the BladderStatus unknownNCT03529890Phase 2
- Salivary Ap4A, SCCA, TROP2 in Oral Cancer PatientsStatus unknownNCT03529604
- Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell CarcinomaCompletedNCT03524326Phase 1
- The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor ThrombusStatus unknownNCT03520257Phase 2
- Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell CarcinomaCompletedNCT03519542
- Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With MetastasisStatus unknownNCT03518502Phase 4
- Epidemiology of Merkel Carcinomas in the Bas-RhinStatus unknownNCT03518307
- Intravital Microscopy (IVM) in Patients With Peritoneal Carcinomatosis (PC)CompletedNCT03517852Not applicable
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- Management of Spontaneous Ruptured Hepatocellular CarcinomaCompletedNCT03516890
- Expanding Phase III Study of Tyroserleutide for InjectionStatus unknownNCT03516448Phase 3
- A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCCCompletedNCT03516071Phase 2
- Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT03515369Phase 4
- Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung CancerCompletedNCT03515252Phase 1
- Early Response Evaluation of Proton Therapy by PET-imaging in Squamous Cell Carcinoma Located in the Head and NeckTerminatedNCT03513042
- The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma PatientsStatus unknownNCT03511703Phase 2
- CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid TumorsCompletedNCT03511391Phase 2
- Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)CompletedNCT03510871Phase 2
- Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular CarcinomaStatus unknownNCT03510416Phase 2
- Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue OxygenationCompletedNCT03510390Not applicable
- Reflectance Confocal Microscopy to Diagnose BCCCompletedNCT03509415
- Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsCompletedNCT03509012Phase 1
- Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisCompletedNCT03508570Phase 1
- Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal TumorsStatus unknownNCT03507998Phase 1